Labfront Joins MassChallenge’s 2022 US Early-Stage Cohort
We're very pleased to announce that earlier this week, Labfront landed a spot in MassChallenge’s 2022 U.S. Early Stage Accelerator program! Labfront was one of over 200 other startups chosen for this year’s accelerator. We join a cohort comprised of entrepreneurs from across the globe who are answering the call to create sustainable change across 42 industries.
Labfront is thrilled to be a part of this program and can’t wait to get started. We’re looking forward to mentoring from MassChallenge’s network of industry experts.
The U.S. Early-Stage program attracts top founders from around the world and provides access to the tools, resources, and talent that founders and corporate innovators need to make transformational impact. By participating in this accelerator, Labfront will receive world-class mentoring from industry experts, tailored programming, unrivalled access to corporate partners and more to bolster our efforts to advance healthcare. We can’t wait to get started!
MassChallenge is the global network for innovators. Headquartered in the United States with eight locations worldwide, it is the non-profit's mission to help bold entrepreneurs disrupt the status quo and create sustainable change. Since launching in 2009, MassChallenge has run programs in 18 countries, supported more than 3,000 startups from around the world, and awarded over $17M in equity-free cash and prizes. Learn more about MassChallenge at masschallenge.org.